Cory berkland.
Fourth KU professor to receive honor, one of the highest honors for an academic inventor.
Na Zhang; Chuda Chittasupho; Chadarat Duangrat; Teruna J. Siahaan; Cory Berkland: 1-May-2017: Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells: Singkome Tima; Songyot Anuchapreeda; Chadarat Ampasavate; Cory Berkland; Siriporn OkonogiThe goal of this work was to fabricate uniform double-walled microspheres comprising PCPH cores and PLG shells designated PLG (PCPH), as well as PLG cores and PCPH shells designated PCPH (PLG), each exhibiting a controllable shell thickness, as a means to potentially achieve advanced drug delivery profiles. Initially, PCPH (15% wt/vol in DCM ...Introduction. Hollow particles, also referred to as capsules or vesicles, are generating interest in industry as well as scientific research. Many active ingredients have been formulated within a capsule core to protect them from the surrounding environment and/or to facilitate sustained release including; adhesives, agrochemicals, catalysts, living cells, flavor oils, pharmaceuticals ...Cory Berkland, professor of pharmaceutical chemistry is pictured on Monday, July 2, 2012, in his lab at the Multidisiplinary Research Building, 2030 Becker Drive. Berkland is developing ways for ...So Cory Berkland and colleagues set out to find new kinds of pharmaceuticals to fight weight gain. Targeting the body’s process of absorbing fat, the researchers designed a class of polymers that capture fat particles called micelles in the intestines so they can’t be digested. Instead, they pass through the gut and are excreted.
Recently, lymphocyte function-associated antigen-1 (LFA-1), a primary cell adhesion molecule, has also been investigated for targeting nanoparticles to human leukemic cell line ( 30, 32 ). Lima et al. reported that certain leukemic cells expressed 5-fold more LFA-1 than normal leukocytes ( 32 ). Since LFA-1 is expressed only on leukocytes, it ...Jim Berkland. James O. Berkland (July 31, 1930 – July 22, 2016) was an American geologist [1] who controversially claimed to be able to predict earthquakes, including the 1989 Loma Prieta earthquake and 1994 Northridge Earthquake [2] and who popularized the idea that some people are earthquake sensitive. He was profiled in a popular 2006 book ...Dr. Kenneth L. Caldwell is a Orthopedist in Pasadena, TX. Find Dr. Caldwell's phone number, address, insurance information, hospital affiliations and more.
Qun Wanga, Syed Jamalb, Michael S. Detamorea, and Cory Berklanda,c,* a Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, KS 66047 b Department of Molecular Biosciences, University of Kansas, Lawrence, KS 66047 c Department of Pharmaceutical Science, University of Kansas, Lawrence, KS 66047 Abstract
Qun Wanga, Syed Jamalb, Michael S. Detamorea, and Cory Berklanda,c,* a Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, KS 66047 b Department of Molecular Biosciences, University of Kansas, Lawrence, KS 66047 c Department of Pharmaceutical Science, University of Kansas, Lawrence, KS 66047 AbstractCory Berkland Multiple sclerosis represents the world's most common cause of neurological disability in young people and is attributed to a loss of immune tolerance toward proteins of the myelin ...AU - Berkland, Cory. AU - Pack, Daniel W. AU - Kim, Kyekyoon. N1 - Funding Information: We would like to thank Dr. Kevin Kim's research group for the FFESS set-up for polymer spraying experiments, especially Dr. HoChul Kang. The tungsten needles used in this work were donated by Point Technologies. Scanning electron micrographs were attained at ...Cory J. Berkland [email protected] Department of Chemical and Petroleum Engineering, University of Kansas, 1530 West 15th Street, Lawrence, KS, 66045 USA. Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, KS, 66047 USA. E-mail: [email protected] Search for more papers by this authorName: CORY BERKLAND Phone: (785) 864-1455 Email: [email protected]. Business Contact. Name: CORY BERKLAND Phone: (785) 764-0125 Email: [email protected]. Research Institution. N/A . Abstract. PROJECT SUMMARY/ABSTRACT Hereditary Hemochromatosis (HH) is one of the most common genetic disorders in the United States affecting
Congratulations to our collaborator, Prof. Cory Berkland, who was recognized last week with the Jim Baxendale Commercialization Award! Prof. Berkland...
Recently, lymphocyte function-associated antigen-1 (LFA-1), a primary cell adhesion molecule, has also been investigated for targeting nanoparticles to human leukemic cell line ( 30, 32 ). Lima et al. reported that certain leukemic cells expressed 5-fold more LFA-1 than normal leukocytes ( 32 ). Since LFA-1 is expressed only on leukocytes, it ...
Introduction Microsphere-based tissue engineering scaffold designs have attracted significant attention in recent years [ 1-7], as the microspheres as building blocks offer several benefits, including easeNashwa El-Gendy1, Kristin L. Aillon1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047 ... Fax: (785) 864- 1454. [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourBiography —. Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry.Patent number: 11390795. Abstract: The invention is directed to delayed gelation agents comprising a degradable polymeric cage containing therein one or more gelation agents. The cage degrades in situ, e.g, in an oil reservoir, thus releasing the gelation agent (s), which can then crosslink second polymers in situ to form a gel. Type: Grant.Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USANabil A Alhakamy 1 , David T Curiel 2 , Cory J Berkland 3 Affiliations 1 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; …
Brittany L Hartwell 1 , Chad J Pickens 2 , Martin Leon 3 , Cory Berkland 1 2 4 Affiliations 1 Bioengineering Graduate Program, University of Kansas 1520 West 15th Street, Lawrence, Kansas 66045, United States. 2 Department of Pharmaceutical Chemistry, University of Kansas 2095 Constant Avenue ...Lianjun Shi 1 , Cory Berkland. Affiliation 1 Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KS 66047. PMID: 18797513 PMCID: PMC2537468 DOI: 10.1021/ma070443o Abstract Hollow nanoparticles represent an emerging area of development for the encapsulation of active ingredients. ...Cory Berkland [email protected] Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047===Search for more papers by this authorBrian T. Andrews, Scott Barbay, Sheila Tsau, Cory Berkland, Jakob M. Townsend, Michael S. Detamore, Chad A. Tuchek, Randolph J. Nudo Surgical Decision-Making in Microvascular Reconstruction of ...Calcium-crosslinked LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells Supang Khondee1, Abdulgader Baoum1, Teruna J. Siahaan1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047 2Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KSคณะเทคนิคการแพทย์ มหาวิทยาลัยเชียงใหม่ 110 ถนนอินทวโรรส ตำบล ...So Cory Berkland and colleagues set out to find new kinds of pharmaceuticals to fight weight gain. Targeting the body's process of absorbing fat, the researchers designed a class of polymers that capture fat particles called micelles in the intestines so they can't be digested. Instead, they pass through the gut and are excreted.
PRECLINICAL STUDY The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells Wei Bin Fang • Min Yao • Iman Jokar • Nabil Alhakamy • Cory Berkland • Jin Chen • Dana Brantley-Sieders • Nikki Cheng Received: 4 December 2014/Accepted: 24 February 2015/Published online: 6 March 2015Cory Berkland PhD, University of Illinois, 2003 MS, University of Illinois, 2001 BS, Iowa State University, 1998 View All People contact info: Email: [email protected] The Berkland lab focuses on developing new therapeutics and biomaterials for improving human health
Cory Berkland. The University of Kansas. ... CJ Berkland, ML Forrest. Advanced drug delivery reviews 61 (6), 457-466, 2009. 897: 2009: Nanotechnology in vaccine delivery. Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. HHS Author Manuscripts. Nanoparticles of PLG have been widely studied for their use in drug delivery. 8600 Rockville Pike Bethesda, MD 20894. HHS Vulnerability Disclosure.Dr. Brian T. Andrews is a Plastic Surgeon in Iowa City, IA. Find Dr. Andrews's phone number, address, insurance information, hospital affiliations and more.Nashwa El-Gendy, Mark M. Bailey, Cory Berkland; Pages 283-312. Liposomes for Pulmonary Drug Delivery. Janani Swaminathan, Carsten Ehrhardt; Pages 313-334. Nanoparticles for Pulmonary Delivery. Alan B. Watts, Robert O. Williams III; Pages 335-366. Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy.Cory Berkland Double-walled microspheres represent an increasingly important class of drug delivery devices that provide enhanced control of drug delivery schedules. Clearly, the overall particle size and shell thickness are important parameters in …Chad J Pickens 1 , Stephanie N Johnson 1 , Melissa M Pressnall 1 , Martin A Leon 2 , Cory J Berkland 1 2 3 Affiliations 1 Department of Pharmaceutical Chemistry , University of Kansas , 2095 Constant Avenue , Lawrence , Kansas 66047 , United States.Number of Employee Profiles 2. Bond Biosciences has 2 current employee profiles, including Co-founder and Chief Scientific Officer Cory Berkland. Cory Berkland Co-founder and Chief Scientific Officer.
PRECLINICAL STUDY The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells Wei Bin Fang • Min Yao • Iman Jokar • Nabil Alhakamy • Cory Berkland • Jin Chen • Dana Brantley-Sieders • Nikki Cheng Received: 4 December 2014/Accepted: 24 February 2015/Published online: 6 March 2015
About. Dr. Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. He is taking a partial leave as Distinguished Professor at The University of Kansas to advance the business and to ensure the development and clinical trial progression of BBI-001.
Cory J Berkland. Department of Chemical and Petroleum Engineering, University of Kansas, USA. Department of Pharmaceutical Chemistry, University of Kansas ...Lianjun Shi 1 , Cory Berkland. Affiliation 1 Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KS 66047. PMID: 18797513 PMCID: PMC2537468 DOI: 10.1021/ma070443o Abstract Hollow nanoparticles represent an emerging area of development for the encapsulation of active ingredients. ...The objective of this work is to use colloidal gel from alginate-chitosan-PLGA complex to deliver Ac-PLP-BPI-NH 2-2 peptide in a controlled-release manner as a vaccine-like therapeutic to suppress experimental autoimmune encephalomyelitis (EAE) in the mouse model.Oppositely charged PLGA nanoparticles were prepared by a solvent diffusion method.J Pharm Innov (2010) 5:70-71 DOI 10.1007/s12247-010-9084- EDITORIAL Cory Berkland Published online: 16 July 2010 # Springer Science+Business Media, LLC 2010 In the pharmaceutical community, nanotechnology has that particles with a diameter larger than about 10 nm may become the flavor of the day for anything with a size or persist in circulation due to exclusion from renal filtration ...Dr. Vincent H. Key is a Orthopedist in Kansas City, KS. Find Dr. Key's phone number, address, insurance information, hospital affiliations and more.Cory Berkland Type 1 diabetes (T1D) is an autoimmune disorder which develops when insulin-producing, pancreatic beta cells are destroyed by an aberrant immune response.Chairperson: Dr. Cory Berkland Date approved: November 8, 2016 . iii Abstract Multiple Sclerosis (MS) is an autoimmune disease characterized by the breakdown of immune tolerance towards autoantigen in the myelin sheath surrounding the neurons. CurrentSentinel lymph node (SLN) mapping has been widely used to predict the metastatic spread of primary tumor to regional lymph nodes in clinical practice. In this research, a new near-infrared (NIR)-emitting polymer nanogel (NIR-PNG) having a hydrodynamic diameter of about 30 nm, which is optimal for lymph node uptake, was developed. The NIR-emitting polymer nanoprobes were designed and ...
Noncovalently associated cell-penetrating peptides for gene delivery applications. 2013 Jun;4 (6):741-57. doi: 10.4155/tde.13.44. Nabil A Alhakamy Adane S Nigatu Cory J Berkland Joshua D Ramsey. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA. 23738670. INTRODUCTION. Autoimmune diseases, such as multiple sclerosis (MS), 1, 2 type 1 diabetes (T1D), 3-7 neuromyelitis optica, 8, 9 and lupus erythematosus, 10, 11 involve loss of tolerance to self-antigens in autoreactive B cells, leading to tissue damage, disability, and death. In individuals afflicted by T1D, the insulin-producing beta cells in the pancreas are targeted by an autoimmune ...Brittany L. Hartwell, Aaron Smalter Hall, David Swafford, Bradley P. Sullivan, Aaron Garza, Joshua O. Sestak, Laura Northrup, and Cory Berkland. Molecular Dynamics of Multivalent Soluble Antigen Arrays Support a Two-Signal Co-delivery Mechanism in the Treatment of Experimental Autoimmune Encephalomyelitis.Instagram:https://instagram. mindset synbabyashlee downloadjosh svatyhow is the neutral stimulus related to the cs We welcome panelists: Cory Berkland, PhD. Cory Berkland, PhD: Cory Berkland holds the Solon E. Summerfield Distinguished Professorship in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas.He will be starting as a Professor in the Biomedical Engineering Department and the … primary versus secondarypelican mission sit in kayak Development of budesonide nanocluster dry powder aerosols: Processing Development of budesonide nanocluster dry powder aerosols: Processing El‐Gendy, Nashwa; Selvam, Parthiban; Soni, Pravin; Berkland, Cory 2012-09-01 00:00:00 Aerosolized medicine is one of the fastest growing areas in the pharmaceutical industry. Dry powder …Brittany L. Hartwell, 1 Chad J. Pickens, 2 Martin Leon, 3 Laura Northrup, 2 Matthew Christopher, 2 J. Daniel Griffin, 1 Francisco Martinez-Becerra, 4 and Cory Berkland 1, 2, 5, * Brittany L. Hartwell 1 Bioengineering Graduate Program, University of Kansas 1520 West 15 th Street, Lawrence, KS 66045, USA nba player andrew wiggins Nashwa El-Gendy, Mark M. Bailey, Cory Berkland; Pages 283-312. Liposomes for Pulmonary Drug Delivery. Janani Swaminathan, Carsten Ehrhardt; Pages 313-334. Nanoparticles for Pulmonary Delivery. Alan B. Watts, Robert O. Williams III; Pages 335-366. Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy.Chandrashekar Raman 1 , Cory Berkland, Kyekyoon Kim, Daniel W Pack. Affiliation 1 Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, IL 61801, United States. PMID: 15773062 DOI: 10.1016/j.jconrel.2004.11.012 Abstract Modeling release of small molecules from degradable microspheres is important to the design of ...INTRODUCTION. Autoimmune diseases, such as multiple sclerosis (MS), 1, 2 type 1 diabetes (T1D), 3-7 neuromyelitis optica, 8, 9 and lupus erythematosus, 10, 11 involve loss of tolerance to self-antigens in autoreactive B cells, leading to tissue damage, disability, and death. In individuals afflicted by T1D, the insulin-producing beta cells in the pancreas are targeted by an autoimmune ...